19 results
DEF 14A
TSBX
Turnstone Biologics Corp.
22 Apr 24
Definitive proxy
4:28pm
was a healthcare investment banker at Raymond James & Associates, served as manager of corporate development at Veritas Medicine, and was a summer associate … , a healthcare investment firm, where he has held the position of managing director since 2015. He has played a critical role in Versant's company
10-K
2023 FY
TSBX
Turnstone Biologics Corp.
21 Mar 24
Annual report
8:51pm
Healthcare. Our clinical development and regulatory organization is led by our interim Chief Medical Officer, Michael Burgess, MBChB, Ph.D., who has … of products;
consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;
mandated modification of promotional
10-Q
tux 55mws8hdy0xir
1 Sep 23
Quarterly report
4:39pm
424B4
x5ggwygf a24z
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
w019db
23 Jun 23
IPO registration (amended)
9:49pm
S-1
lt63tmj y9c
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
hmm5kx3ngcqyeeqj8n3j
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
iou8o73n0hlzjp271zh
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.10
z96un4 0azy0011z
12 Jun 23
IPO registration
4:28pm
S-1
EX-4.2
osnnj ce05ysn0nw
12 Jun 23
IPO registration
4:28pm
DRS
yheavbk3rbwjk670ujo
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
6v15nefbc2ilg on9
15 May 23
Draft registration statement
12:00am
DRS
EX-2.1
mzbp4vyscxrs5jmc980
15 May 23
Draft registration statement
12:00am
DRS
EX-10.10
tb1q5sb
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next